US5229518AExpiredUtilityPatentIndex 62
Isomerically pure 2-piperidone compounds
Est. expiryMar 6, 2011(expired)· nominal 20-yr term from priority
C07D 211/76C07D 211/86C07D 213/69
62
PatentIndex Score
4
Cited by
15
References
9
Claims
Abstract
The present invention relates to intermediates useful in the process for the preparation of a compound of the formula: ##STR1## wherein R 2a is hydrogen or loweralkyl, R 2b is hydrogen, loweralkyl, cycloalkyl or phenyl and R 1 is loweralkyl, cycloalky, cycloalkylalkyl, phenyl or benzyl. These intermediates are compounds of the formula: ##STR2## wherein R 1 , R 2a and R 2b are defined as above.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A substantially isomerically pure compound of the formula: ##STR6## wherein R 2a is hydrogen or loweralkyl, R 2b is hydrogen, loweralkyl, cycloalkyl or phenyl and R 1 is loweralkyl, cycloalkyl, cycloalkylalkyl, phenyl or benzyl.
2. The compound of claim 1 wherein R 2a and R 2b are methyl and R 1 is cyclohexylmethyl or R 2a is hydrogen, R 2b is phenyl and R 1 is benzyl.
3. The substantially isomerically pure compound of the formula: ##STR7##
4. A substantially isomerically pure compound of the formula: ##STR8## wherein R 2a is hydrogen or loweralkyl, R 2b is hydrogen, loweralkyl, cycloalkyl or phenyl and R 1 is loweralkyl, cycloalkyl, cycloalkylalkyl, phenyl or benzyl.
5. The compound of claim 4 wherein R 2a and R 2b are methyl and R 1 is cyclohexylmethyl or R 2a is hydrogen, R 2b is phenyl and R 1 is benzyl.
6. A substantially isomerically pure compound of the formula: ##STR9## wherein R 2a is hydrogen or loweralkyl, R 2b is hydrogen, loweralkyl, cycloalkyl or phenyl and R 1 is loweralkyl, cycloalkyl, cycloalkylalkyl, phenyl or benzyl.
7. The compound of claim 6 wherein R 2a and R 2b are methyl and R 1 is cyclohexylmethyl or R 2a is hydrogen, R 2b is phenyl and R 1 is benzyl.
8. The substantially isomerically pure compound of the formula: ##STR10##
9. The substantially isomerically pure compound of the formula: ##STR11##Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.